1. Association of genetic polymorphisms in MIF with breast cancer risk in Chinese women
   Shuai Lin et al, 2017, Clinical and Experimental Medicine CrossRef
2. Macrophage migration inhibitory factor promoter polymorphisms (−794CATT5–7) as potential biomarker for early‐stage cervical cancer
   Suhui Wu et al, 2017, Journal of Obstetrics and Gynaecology Research CrossRef
3. Expression of MIF and c-erbB-2 in endometrial cancer
   WEI XIAO et al, 2016, Molecular Medicine Reports CrossRef
4. Association Study Between Macrophage Migration Inhibitory Factor-173 Polymorphism and Acute Myeloid Leukemia in Taiwan
   Latha Ramireddy et al, 2014, Cell Biochemistry and Biophysics CrossRef
5. Emerging Role of the Macrophage Migration Inhibitory Factor Family of Cytokines in Neuroblastoma. Pathogenic Effectors and Novel Therapeutic Targets?
   Eugenio Cavalli et al, 2020, Molecules CrossRef
6. Macrophage Migration Inhibitory Factor (MIF): Biological Activities and Relation with Cancer
   Camila Cristina Guimarães Nobre et al, 2017, Pathology & Oncology Research CrossRef
7. The Formation and Therapeutic Update of Tumor-Associated Macrophages in Cervical Cancer
   Qun Wang et al, 2019, International Journal of Molecular Sciences CrossRef
8. Genetic susceptibility in cervical cancer: From bench to bedside
   Afsane Bahrami et al, 2018, Journal of Cellular Physiology CrossRef
9. IPA Analysis of Cervicovaginal Fluid from Precancerous Women Points to the Presence of Biomarkers for the Precancerous State of Cervical Carcinoma
   Xaveer Van Ostade et al, 2014, Proteomes CrossRef
10. Lessons and implications from association studies and post-GWAS analyses of cervical cancer
    Dan Chen et al, 2015, Trends in Genetics CrossRef
11. Macrophage migration inhibitory factor may contribute to the occurrence of multiple primary lung adenocarcinomas
    Wei Liu et al, 2023, Clinical and Translational Medicine CrossRef
12. Update September 2012
    Francine Blei, 2012, Lymphatic Research and Biology CrossRef
13. Novel Association Between CD74 Polymorphisms and Hematologic Toxicity in Patients With NSCLC After Platinum-Based Chemotherapy
    Xiaoming Tan et al, 2014, Clinical Lung Cancer CrossRef
14. Contribution of Macrophage Migration Inhibitory Factor -173G/C Gene Polymorphism to the Risk of Cancer in Chinese Population
    Cheng-Di Wang et al, 2015, Asian Pacific Journal of Cancer Prevention CrossRef